Responses
Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1157 GQ1007: the next generation HER2-targeting antibody immune agonist conjugate with robust efficacy and favorable safety profile
Compose a Response to This Article
Other responses
No responses have been published for this article.